Skip to main contentAI and Advanced
/
PAR · NSEMarket ticker unavailable · configure an authorised index feed
PA
NSE · Equity shares · Biotechnology & Drugs-6.59 · -4.04%
Par Drugs and Chemicals PAR
NSE:INR 156.71
BSE:Not available
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for PAR
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 163.3
Day rangeINR 156.71 — INR 168
52-week rangeINR 78.05 — INR 180
Volume10,607
Market cap121.07
P/E7.38
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)103.66
Net Income (INR Cr)13.11
Rev Growth (5 Year %)11.28
EPS Growth (5 Year %)-10.81
P/E Ratio7.38
Book Value91.01
EPS10.65
Price/BV1.72Computed
Research path: Interpret Par Drugs and Chemicals's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
PARPar Drugs and Chemicals1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 129.21 | 119.39 | 101.61 |
| Cash Equivalents | 41.84 | Not available | 0 |
| Other Liabilities Total | 0.24 | 0.27 | Not available |
| Long Term Debt | 0 | 0 | 0 |
| Common Stock Total | 12.3 | 12.3 | 12.3 |
| Other Current Assets Total | 0.22 | 0 | 0 |
| Total Assets | 129.21 | 119.39 | 101.61 |
| Cash | 0 | 7.11 | 33.52 |
| Total Equity | 111.98 | 98.97 | 85.63 |
| Long Term Investments | 27.14 | 25.07 | 0.01 |
| Retained Earnings(Accumulated Deficit) | 99.68 | 76 | 62.65 |
| Total Common Shares Outstanding | 1.23 | 1.23 | 1.23 |
| Tangible Book Valueper Share Common Eq | 91.01 | 80.44 | 69.59 |
| Total Liabilities | 17.23 | 20.42 | 15.98 |
| Total Debt | 0 | 0 | 0 |
| Short Term Investments | 0 | 20.47 | 3.13 |
| Cashand Short Term Investments | 41.84 | 27.58 | 36.65 |
| Total Receivables Net | 16.89 | 21.06 | 18.51 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 3.24 | 3.58 | 3.54 |
| Accounts Receivable-Trade Net | 12.03 | 16.71 | 13.71 |
| Property/Plant/Equipment Total-Net | 37.16 | 38.91 | 41.33 |
| Total Current Liabilities | 13.74 | 16.57 | 12.44 |
| Total Inventory | 5.37 | 6.19 | 4.42 |
| Accounts Payable | 8.19 | 10.89 | 5.36 |
| Other Currentliabilities Total | 5.55 | 5.68 | 7.08 |
| Total Long Term Debt | 0 | 0 | 0 |
| Other Long Term Assets Total | 0.59 | 0.54 | 0.64 |
| Total Current Assets | 64.33 | 54.86 | 59.62 |
| Accumulated Depreciation Total | Not available | -36.18 | -32.53 |
| Prepaid Expenses | Not available | 0.03 | 0.04 |
| Current Portof LT Debt/Capital Leases | Not available | 0 | 0 |
| Additional Paid-In Capital | Not available | 10.67 | 10.67 |
| Property/Plant/Equipment Total-Gross | Not available | 75.09 | 73.87 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.9
Price to Sale Ratio1.17
Margins
Operating Margin 12m12.95
Operating Margin 5y Avg16.26
Net Profit Margin 12m12.65
Net Profit Margin 5y13.06
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,935.4 | 4.64 L | 38.4 | — |
| Divi's Laboratories | INR 7,367.5 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,969.9 | 1.68 L | 72.73 | — |
| Cipla | INR 1,406 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,116.35 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 73.41%
- FII
- 0.09%
- Other
- 26.59%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness - MarketsMojoMarket news · 20 Jul 2026, 8:48 am
Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness MarketsMojo
Par Drugs & Chemicals Ltd is Rated Hold - MarketsMojoMarket news · 19 Jul 2026, 11:22 pm
Par Drugs & Chemicals Ltd is Rated Hold MarketsMojo
Volume Gainers at 4:00 PM IST, July 15: Apollo Sindoori, Par Drugs - HDFC SkyMarket news · 15 Jul 2026, 5:34 pm
Volume Gainers at 4:00 PM IST, July 15: Apollo Sindoori, Par Drugs HDFC Sky
Volume Gainers Today, July 15, 2026: Apollo Sindoori Hotels, Century Enka, Ksolves India Among Most Active - HDFC SkyMarket news · 15 Jul 2026, 12:49 pm
Volume Gainers Today, July 15, 2026: Apollo Sindoori Hotels, Century Enka, Ksolves India Among Most Active HDFC Sky
L&T Technology Services Jumps 7.29% In Intraday Trade - HDFC SkyMarket news · 15 Jul 2026, 11:14 am
L&T Technology Services Jumps 7.29% In Intraday Trade HDFC Sky
Price to earnings forward of Par Drugs and Chemicals Limited – NSE:PAR - TradingViewMarket news · 26 Jun 2026, 2:48 pm
Price to earnings forward of Par Drugs and Chemicals Limited – NSE:PAR TradingView
Corporate actions
Events
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
- annual General MeetingAGM
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
Rusaka Markets Community
Discussion and sentiment for Par Drugs and Chemicals
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- PAR
Questions
Stock FAQ
What is the symbol and ISIN of Par Drugs and Chemicals?
Par Drugs and Chemicals has the symbol PAR and ISIN - INE04LG01015.
What is the current price of Par Drugs and Chemicals?
Par Drugs and Chemicals is currently trading at INR 156.71.
What are the year high and year low of Par Drugs and Chemicals?
Par Drugs and Chemicals has a year high of INR 180.00 and a year low of INR 78.05.
What is the market capitalization of Par Drugs and Chemicals?
Par Drugs and Chemicals has a market capitalization of INR 121.07 crore.
What is the P/E ratio of Par Drugs and Chemicals?
Par Drugs and Chemicals has a P/E ratio of 7.38.
What is the dividend yield of Par Drugs and Chemicals?
Par Drugs and Chemicals has a dividend yield of 0.00%.
How is the financial performance of Par Drugs and Chemicals based on revenue, net income, and EPS?
Par Drugs and Chemicals has revenue of INR 103.66 crore, net income of INR 13.11 crore, and EPS of INR 10.65.
What is the book value of Par Drugs and Chemicals?
Par Drugs and Chemicals has a book value of INR 91.01.
What is the debt-to-equity ratio of Par Drugs and Chemicals?
Par Drugs and Chemicals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Par Drugs and Chemicals?
Par Drugs and Chemicals has a price-to-book ratio of 1.72 and a price-to-sales ratio of 1.17.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.